The novel echo‐guided ProGlide technique during percutaneous transfemoral transcatheter aortic valve implantation

Honda, Yohsuke; Araki, Motoharu; Yamawaki, Masahiro; Tokuda, Takahiko; Tsutumi, Masakazu; Mori, Shinsuke; Sakamoto, Yasunari; Kobayashi, Noboru; Hirano, Keisuke; Ito, Yoshiaki

doi:10.1111/joic.12468

Cited by 22 publications

(18 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The use of percutaneous closure devices to seal femoral arterial access sites has been increasing during the past decade. [10–13] Because it is widely accepted that percutaneous arterial closure offers a wide range of advantages, we perform VA-ECMO using a totally percutaneous approach when possible. Among the various percutaneous arterial closure devices, suture-mediated systems such as Perclose ProGlide, offer the advantages of surgical type of vessel closure.…”

Section: Discussionmentioning

confidence: 99%

Feasibility and safety of total percutaneous closure of femoral arterial access sites after veno-arterial extracorporeal membrane oxygenation

Liu

Han

et al. 2019

Medicine

View full text Add to dashboard Cite

To evaluate the safety and efficacy of total percutaneous closure of the femoral artery access site after veno-arterial extracorporeal membrane oxygenation (VA-ECMO) with the Perclose ProGlide device.This retrospective observational study during an almost 2-year period included 21 patients who underwent VA-ECMO in whom the femoral artery puncture site was closed percutaneously with Perclose ProGlide devices. Technical success was defined as successful arterial closure of the common femoral artery, without the need for additional surgical or endovascular procedures. Access site complications were recorded at 24 hours and 30 days after arterial closure, such as major bleeding requiring transfusion or surgical intervention, minor bleeding, groin infection, pseudoaneurysm, and lymphocele.Technical success was achieved in 20 patients (95.2%). One patient required surgical repair for an access site pseudoaneurysm. Eighteen femoral arteries were closed with 2 devices each, while 3 patients required the use of a third device for femoral artery access site closure to achieve adequate hemostasis. No arterial thrombosis, arterial dissection, arterial stenosis, groin infection, or arteriovenous fistula occurred during the periprocedural period (within 24 hours of arterial closure) or during 30-day follow-up.Percutaneous closure with the Perclose ProGlide device is a feasible procedure for closing femoral arterial access sites after VA-ECMO, with a low incidence of access site complications.

show abstract

Section: Discussionmentioning

confidence: 99%

Feasibility and safety of total percutaneous closure of femoral arterial access sites after veno-arterial extracorporeal membrane oxygenation

Liu

Han

et al. 2019

Medicine

View full text Add to dashboard Cite

show abstract

“…Although studies of the complication and success rates of percutaneous closure devices have accumulated in the past two decades (5,6,8,9,11,13,(17)(18)(19)(20), there is no data on applying the PP technique VA-ECMO patients. Furthermore, there are no comparisons of the PP method between VA-ECMO and percutaneous EVAR patients.…”

Section: Introductionmentioning

confidence: 99%

Comparison of Success Rate and Complications of Totally Percutaneous Decannulation in Patients With Veno-Arterial Extracorporeal Membrane Oxygenation and Endovascular Aneurysm Repair

Liu

et al. 2021

Front. Med.

View full text Add to dashboard Cite

Background: Total percutaneous closure for the site of femoral arterial puncture using Perclose ProGlide (PP) has become prevalent post-percutaneous endovascular aortic repair (EVAR) and veno-arterial extracorporeal membrane oxygenation (VA-ECMO).Objective: To evaluate the safety and efficacy of total percutaneous closure of the femoral artery access site post-EVAR compared with VA-ECMO.Methods: This was a retrospective observational study conducted over 4 years, including 88 patients who underwent EVAR (64 patients) and VA-ECMO (24 patients). Perclose ProGlide devices were used in the femoral artery puncture sites closed percutaneously. In this study, technical success was defined as successful arterial closure of the common femoral artery (CFA) without additional surgical or endovascular procedures to prevent vessel leaking. Access site complications, including overt bleeding requiring transfusion or surgical intervention, minor bleeding, tinea cruris, pseudoaneurysm, and lymphocele, were recorded 24 h and 30 days after arterial closure.Results: Each group's technical success rates were 95.8% (VA-ECMO) and 92.2% EVAR, respectively. There were no differences in the periprocedural complications of major bleeding, pseudoaneurysm, minor bleeding, acute limb ischemia, and groin infection. Furthermore, we did not observe any complications such as arterial thrombosis, dissection, stenosis, arteriovenous fistula, hematoma, groin infection, or lymphocele at the access site by following-up an ultrasound examination. There was no significant difference in the technical success rate of percutaneous closure by the PP device in the EVAR and VA-ECMO oxygenation groups. Also, no periprocedural or 30-day complications were observed at the access site of the EVAR and VA-ECMO patients.

show abstract

“…In this case, femoral occlusion occurred in the absence of these recognized risk factors, suggesting the need to carefully use ProGlide to avoid devicerelated complications, such as stenosis or occlusion of a puncture site. An echo-guided technique, confirming ProGlide without interference with the posterior wall at the puncture site before depressing the needle plunger of the ProGlide, might be useful to prevent such complications [5].…”

Section: Discussionmentioning

confidence: 99%

Serial angioscopy during treatments for ProGlide-related femoral occlusion following transcatheter aortic valve implantation

Tsuda

Shutta

Kawamura

et al. 2021

Journal of Cardiology Cases

View full text Add to dashboard Cite

Percutaneous transfemoral (TF) approach using vascular closure devices (VCDs) is one of the most favorable strategies in transcatheter aortic valve implantation (TAVI) [1,2]. However, VCDrelated vascular complications, such as stenosis, occlusion, bleeding, hematoma, and the formation of a pseudoaneurysm, sometimes occur [3]. For these complications, especially stenosis or occlusion, endovascular therapy (EVT) is considered one of the viable options; however, the strategy of EVT has not been established. We report a case of a ProGlide (Abbott Vascular, Santa Clara, CA, USA)-related femoral occlusion treated with balloon angioplasty under angioscopy guidance. Case reportAn 83-year-old woman with severe aortic stenosis underwent TF-TAVI using a 14 Fr e-sheath (Edwards Lifesciences, Irvine, CA, USA) via the right femoral artery (FA). Pre-procedural computed

show abstract

The novel echo‐guided ProGlide technique during percutaneous transfemoral transcatheter aortic valve implantation

Abstract: This novel Echo-guided ProGlide technique was associated with a lower rate of major vascular complications, particularly ProGlide complications during percutaneous TF-TAVI.

Cited by 22 publications

References 29 publications

Feasibility and safety of total percutaneous closure of femoral arterial access sites after veno-arterial extracorporeal membrane oxygenation

Feasibility and safety of total percutaneous closure of femoral arterial access sites after veno-arterial extracorporeal membrane oxygenation

Comparison of Success Rate and Complications of Totally Percutaneous Decannulation in Patients With Veno-Arterial Extracorporeal Membrane Oxygenation and Endovascular Aneurysm Repair

Serial angioscopy during treatments for ProGlide-related femoral occlusion following transcatheter aortic valve implantation

Contact Info

Product

Resources

About